Terms: = Colorectal cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Treatment
172 results:
1. Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration.
Piscitelli J; Reddy MB; Wollenberg L; Del Frari L; Gong J; Wood L; Zhang Y; Matschke K; Williams JH
Clin Pharmacokinet; 2024 Apr; 63(4):483-496. PubMed ID: 38424308
[TBL] [Abstract] [Full Text] [Related]
2. Factors associated with sexual dysfunction in patients with colorectal cancer in Iran: a cross-sectional study.
Dahouri A; Sahebihagh MH; Gilani N
Sci Rep; 2024 Feb; 14(1):4915. PubMed ID: 38418573
[TBL] [Abstract] [Full Text] [Related]
3. End-to-end prognostication in colorectal cancer by deep learning: a retrospective, multicentre study.
Jiang X; Hoffmeister M; Brenner H; Muti HS; Yuan T; Foersch S; West NP; Brobeil A; Jonnagaddala J; Hawkins N; Ward RL; Brinker TJ; Saldanha OL; Ke J; Müller W; Grabsch HI; Quirke P; Truhn D; Kather JN
Lancet Digit Health; 2024 Jan; 6(1):e33-e43. PubMed ID: 38123254
[TBL] [Abstract] [Full Text] [Related]
4. Impact of posaconazole and diltiazem on pharmacokinetics of encorafenib, a BRAF V600 kinase inhibitor for melanoma and colorectal cancer with BRAF mutations.
Hahn E; Chavira R; Wollenberg L; Tan W; Reddy MB
Clin Transl Sci; 2023 Dec; 16(12):2675-2686. PubMed ID: 37837178
[TBL] [Abstract] [Full Text] [Related]
5. Benefits of Soybean in the Era of Precision Medicine: A Review of Clinical Evidence.
Kang JH; Dong Z; Shin SH
J Microbiol Biotechnol; 2023 Dec; 33(12):1552-1562. PubMed ID: 37674385
[TBL] [Abstract] [Full Text] [Related]
6. Pre- and post-treatment FDG PET-CT as a predictor of patient outcomes in anal squamous cell carcinoma: A systematic review and meta-analysis.
Mac Curtain BM; Qian W; Bell J; O'Mahony A; Temperly HC; Ng ZQ
J Med Imaging Radiat Oncol; 2023 Sep; 67(6):634-646. PubMed ID: 37573606
[TBL] [Abstract] [Full Text] [Related]
7. Relationship Between Cetuximab Target-Mediated Pharmacokinetics and Progression-Free Survival in Metastatic colorectal cancer Patients.
Lobet S; Paintaud G; Azzopardi N; Passot C; Caulet M; Chautard R; Desvignes C; Capitain O; Tougeron D; Lecomte T; Ternant D
Clin Pharmacokinet; 2023 Sep; 62(9):1263-1274. PubMed ID: 37442917
[TBL] [Abstract] [Full Text] [Related]
8. Predictive value of
Suleimanov A; Saduakassova A; Vinnikov D; Pokrovsky V; Mamyrbekova S; Daniyarova A; Kozhabek L
F1000Res; 2022; 11():1158. PubMed ID: 37360938
[No Abstract] [Full Text] [Related]
9. Impact of routine preoperative
Mogollón-González M; Conde-Muiño R; Rodríguez-Fernández A; Navarro-Pelayo M; Domínguez-Bastante M; Palma P
J Surg Oncol; 2023 Aug; 128(2):295-303. PubMed ID: 37092877
[TBL] [Abstract] [Full Text] [Related]
10. Effect of Food and a Proton-Pump Inhibitor on the Absorption of Encorafenib: An
Piscitelli J; Hens B; Tomaszewska I; Wollenberg L; Litwiler K; McAllister M; Reddy M
Mol Pharm; 2023 May; 20(5):2589-2599. PubMed ID: 37037186
[TBL] [Abstract] [Full Text] [Related]
11. Comparison of 18 F-FDG and 68 Ga-FAPI-04 Uptake in Postoperative Re-evaluation of Gastric, Duodenal, and colorectal cancers.
Liu H; Yang X; Liu L; Qu G; Chen Y
Clin Nucl Med; 2023 Apr; 48(4):304-308. PubMed ID: 36800254
[TBL] [Abstract] [Full Text] [Related]
12. Underutilization of pretreatment fertility preservation counseling in reproductive-age women with gastrointestinal cancer.
Gudmundsdottir H; Glasgow AE; Bews KA; Ruddy KJ; Thiels CA; Shenoy CC
Eur J Surg Oncol; 2023 Mar; 49(3):667-672. PubMed ID: 36746735
[TBL] [Abstract] [Full Text] [Related]
13. Prediction of Drug Synergism between Peptides and Antineoplastic Drugs Paclitaxel, 5-Fluorouracil, and Doxorubicin Using In Silico Approaches.
Vale N; Pereira M; Santos J; Moura C; Marques L; Duarte D
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613510
[TBL] [Abstract] [Full Text] [Related]
14. A predictive model for early therapeutic efficacy of colorectal liver metastases using multimodal MRI data.
Su X; Zhang H; Wang Y
J Xray Sci Technol; 2023; 31(2):357-372. PubMed ID: 36591694
[TBL] [Abstract] [Full Text] [Related]
15. Response to first line platinum-based chemotherapy in mismatch repair deficient (MMRd)/ microsatellite instability high (MSI-high) endometrial carcinoma.
Colomba E; Alexandre J; Le Teuff G; Genestie C; Coupez D; Coquard IR; Brachet PE; de Percin S; Sajous C; Fabbro M; Delanoy N; Joly F; Frenel JS; Pautier P; Leary A
Gynecol Oncol; 2023 Feb; 169():78-84. PubMed ID: 36521352
[TBL] [Abstract] [Full Text] [Related]
16. Chemoradiotherapy for elderly patients with rectal cancer: A single-institution study.
Uslu GH; Rakici SY
J Cancer Res Ther; 2022 Dec; 18(Supplement):S397-S404. PubMed ID: 36510994
[TBL] [Abstract] [Full Text] [Related]
17. 18 F-FDG PET/CT parameters for prediction of response to neoadjuvant therapy and prognosis in rectal cancer.
Ebinç S; Güzel Y; Oruç Z; Kömek H; Kalkan Z; Can C; Taşdemir B; Urakçi Z; Kaplan MA; Küçüköner M; Işikdoğan A
Nucl Med Commun; 2023 Jan; 44(1):81-90. PubMed ID: 36437550
[TBL] [Abstract] [Full Text] [Related]
18. A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancer.
Carlsson G; Koumarianou A; Guren TK; Haux J; Katsaounis P; Kentepozidis N; Pfeiffer P; Brændengen M; Mavroudis D; Taflin H; Skintemo L; Tell R; Papadimitriou C
ESMO Open; 2022 Oct; 7(5):100589. PubMed ID: 36183444
[TBL] [Abstract] [Full Text] [Related]
19. Predicting neoadjuvant chemoradiotherapy response with functional imaging and liquid biomarkers in locally advanced rectal cancer.
Pham TT; Lim S; Lin M
Expert Rev Anticancer Ther; 2022 Oct; 22(10):1081-1098. PubMed ID: 35993178
[TBL] [Abstract] [Full Text] [Related]
20. A pilot study investigating the role of
Smith D; Joon DL; Knight K; Sim J; Schneider M; Lau E; Foroudi F; Khoo V
J Med Radiat Sci; 2022 Dec; 69(4):439-447. PubMed ID: 35906833
[TBL] [Abstract] [Full Text] [Related]
[Next]
